PMH25 COST-EFFECTIVENESS OF ESCITALOPRAM VERSUS VENLAFAXINE IN SECOND-LINE TREATMENT OF MAJOR DEPRESSIVE DISORDER (MDD) IN SWEDEN
N Despiégel, N Danchenko, K MamanVolume:
12
Year:
2009
Language:
english
DOI:
10.1016/s1098-3015(10)73946-2
File:
PDF, 85 KB
english, 2009